Valuation: Sunzen Biotech

Market Cap 199M 49.05M 43.93M 40.41M 36.61M 68.44M 4.66B 69.72M 482M 193M 2.45B 184M 180M 7.73B P/E 2024
47.7x
P/E 2025 100x
Enterprise Value 200M 49.37M 44.21M 40.67M 36.85M 68.88M 4.69B 70.17M 485M 195M 2.47B 185M 181M 7.78B EV / Sales 2024
2.41x
EV / Sales 2025 2.84x
Free-Float
11.28%
Yield 2024 *
-
Yield 2025 -
10-01 Sunzen Group Berhad Announces Appointment of Yap Shuk Kem as Independent and Non Executive Member of Remuneration Committee, Effective October 01, 2026 CI
10-01 Sunzen Group Berhad Appoints Yap Shuk Kem as Independent and Non Executive Chairperson of the Nomination Committee, Effective October 1, 2026 CI
10-01 Sunzen Group Berhad Appoints Yap Shuk Kem as Independent Non-Executive Director, Effective October 1, 2026 CI
10-01 Sunzen Group Berhad Appoints Yap Shuk Kem as Member of the Audit Committee, Effective October 1, 2026 CI
08-28 Sunzen Group Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2026 CI
06-30 Sunzen Group Berhad Announces Resignation of Khoo Kien Hoe as Independent and Non Executive Chairman of Audit Committee, Effective July 1, 2026 CI
06-30 SUNZEN GROUP BERHAD Announces Resignation of Khoo Kien Hoe as Independent and Non Executive Director, Effective June 30, 2026 CI
06-30 Sunzen Group Berhad Announces Resignation of Khoo Kien Hoe as Independent and Non Executive Chairman of the Remuneration Committee, Effective June 30, 2026 CI
06-30 Sunzen Group Berhad Announces Resignation of Khoo Kien Hoe as Independent and Non Executive Chairman of the Nomination Committee , Effective June 30, 2026 CI
06-30 Sunzen Group Berhad Announces Redesignation of Puan Aida Lim Binti Abdullah from Member to Chairman of Audit Committee, Effective July 1, 2026 CI
05-25 Sunzen Group Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 CI
05-25 Tranche Update on Sunzen Group Berhad's Equity Buyback Plan announced on December 5, 2025. CI
02-27 Tranche Update on Sunzen Group Berhad's Equity Buyback Plan announced on December 5, 2025. CI
1 month-2.22%
3 months-4.35%
6 months-6.38%
Current year-16.98%
1 week 0.22
Extreme 0.22
0.23
1 month 0.22
Extreme 0.22
0.24
Current year 0.22
Extreme 0.215
0.26
1 year 0.22
Extreme 0.215
0.29
3 years 0.22
Extreme 0.215
0.4
5 years 0.18
Extreme 0.18
0.4
10 years 0.03
Extreme 0.03
0.45
Manager TitleAgeSince
Chief Executive Officer 41 2020-06-15
Director of Finance/CFO 61 2019-05-31
Corporate Secretary - 2026-02-26
Director TitleAgeSince
Director/Board Member 41 2020-06-15
Chairman 53 2023-05-25
Director/Board Member 48 2020-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/26 Exercice

Chief Executive Officer

15,000,000 1.8252%
4/10/26 Exercice

Chief Executive Officer

35,840,000 4.3611%
4/10/26 Exercice

Chairman

8,000,000 0.9735%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-25.42%-2.22% 43.05M
+2.28%+1.19%+10.17%-13.62% 264B
+3.85%+1.79%+13.02%-1.92% 82.2B
+1.77%+5.27%-14.55%+16.69% 47.06B
-.--%+0.73%+18.04%+547.12% 45.83B
+0.93%-4.03%+27.06%+7.46% 37.07B
+3.33%-2.38%-2.37%-11.60% 33.28B
-0.39%+1.07%+17.04%+86.79% 31.02B
+0.96%+0.96%-8.53%-7.41% 30B
+1.84%-1.85%-1.58%-22.63% 28.86B
Average +1.46%-0.07%+3.29%+59.86% 59.98B
Weighted average by Cap. +2.03%+0.63%+8.42%+39.69%

Financials

2024 2025
Net sales 95.12M 23.44M 20.99M 19.31M 17.5M 32.71M 2.23B 33.32M 230M 92.45M 1.17B 87.98M 86.11M 3.69B 80.58M 19.86M 17.79M 16.36M 14.82M 27.71M 1.89B 28.23M 195M 78.32M 992M 74.53M 72.95M 3.13B
Net income 6.03M 1.49M 1.33M 1.22M 1.11M 2.07M 141M 2.11M 14.59M 5.86M 74.18M 5.57M 5.46M 234M 2.59M 637K 571K 525K 476K 889K 60.5M 906K 6.26M 2.51M 31.82M 2.39M 2.34M 100M
Net Debt -19.94M -4.91M -4.4M -4.05M -3.67M -6.86M -467M -6.98M -48.27M -19.38M -245M -18.44M -18.05M -774M 1.3M 320K 287K 264K 239K 447K 30.42M 455K 3.15M 1.26M 16M 1.2M 1.18M 50.47M
Projected Income Statement - Annual - Sunzen Biotech
Logo Sunzen Biotech
Sunzen Group Berhad is a Malaysia-based company, which is engaged in fast-moving consumer goods, animal health products, financial solutions, food processing research and development, and raw materials export. The Company's business includes Sunzen Corporation, Finsource Credit, Ecolite, YanMing, and Eye Nation Medical. Sunzen Corporation specializes in animal health and nutrition, manufactures and markets a wide range of related products for both livestock and companion animals. Finsource Credit provides financial products, specializing in business loans. Ecolite is a health and wellness company. It exports its products to other countries like China, Taiwan, Hong Kong, Vietnam, Indonesia, and Singapore as well. Eye Nation Medical provides marketing services to ophthalmic professionals across Malaysia. The four types of products YanMing produces include Cupshape Bird’s Nest, Unsoaked Bird’s Nest, Horn Bird’s Nest and Filament Bird’s Nest.
Employees
168
Date Price Change Volume
26-10-30 MYR 0.2200 -.--% 66,000
26-10-29 MYR 0.2200 -2.22% 1,920,000
26-10-26 MYR 0.2250 +2.27% 1,688,800
  1. Stock Market
  2. Stocks
  3. 0148 Stock